- 28 November 2019
1:00 pm - 2:00 pm
THURSDAY 28 November 2019, 1.00 PM
Auditorium, Level 6, Bancroft Building
What can happen in the 5 years after learning how to play Ludo?
Professor Scott Bell
Lung Bacteria Group
QIMR Berghofer Medical Research Institute
Our current work focusses on other CF pathogens and origins and acquisition pathways including Mycobacterium and the potential spread of infection amongst patients with non-CF lung diseases. Recent results from our research program demonstrating novel data in understanding potential acquisition pathways of respiratory pathogens including from the natural environment and via direct person-to-person spread of bacteria will be discussed. This work is undertaken by a multi-disciplinary research team to support studies of the mechanism of cross-infection using CF as a model. Learning from a clinically-themed based in the Institute over the past five years and insights about what’s happening within our closest health partners and how this could impact on future successful collaborations and funding opportunities will be discussed.
Scott Bell is Executive Director – Research, MNHHS and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH (>320 patients) where he has worked since 1996. He is currently the Editor-in-Chief of the Journal of Cystic Fibrosis. He leads the Lung Bacteria Laboratory at QIMR Berghofer Medical Research Institute. Scott has >240 peer reviewed publications and has received grant support >$22 million over the past 10 years. His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research. He has been principal investigator on numerous pivotal CFTR modulator trials and is global principal investigator on a novel approach to combination therapies for CFTR correction.